Retrospective Study of Germ Cell Tumors of the Central Nervous System
Active, not recruiting
- Conditions
- Germ Cell Tumor of CNS
- Registration Number
- NCT05836701
- Lead Sponsor
- Beijing Sanbo Brain Hospital
- Brief Summary
Retrospectively analyzing the epidemiological and clinical characteristics, treatment, recurrence, prognosis and prognostic factors of the germ-cell tumors of central nervous system in a single center.
- Detailed Description
Clinical data of patients with germ-cell tumors of central nervous system who were treated in the Department of Neuro-oncology, Sanbo Brain Hospital Capital Medical University between January 2007 and December 2022 were retrospectively collected, and the epidemiological and clinical characteristics, treatment, recurrence, prognosis and prognostic factors of the disease were analyzed.
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 500
Inclusion Criteria
- Clinically or pathologically diagnosed as germ cell tumor of the central nervous system.
- Have received antitumor therapy.
- Patients who were clinically diagnosed based on neuroimaging characteristics and response to radiotherapy or chemotherapy were allowed for enrollment.
Exclusion Criteria
- Patients with missing key information such as tumor location, surgical, chemotherapy and radiotherapy data, and post-treatment evaluation.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method treatment regimen 1 year epidemiological characteristics 1 year relapse pattern 1 year prognostic factor 1 year
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Sanbo Brain Hospital Capital Medical University
🇨🇳Beijing, China